Non-viral GMP manufacturing for engineered cells at clinical and commercial scale
Leif Anderson, Chris Abraham
Combining CRISPR and transposon-based technologies for improved sdAb-based CAR-T therapies
Begoña Diez Cabezas, Juan Roberto Rodriguez-Madoz
Optimizing plasmid DNA purification: strategies for reliable and expandable processes
Christy Franco, Jasmina Puc
Making robust choices: evaluating materials in your AAV process
Michael Bodo, Birgit Rogell
Actionable insights for overcoming CMC challenges in TIL therapy: GRIT’s strategic approach
Alex Lei, Sabrina Carmichael